Market Cap (In PLN)
1.36 Billion
Revenue (In PLN)
164.39 Million
Net Income (In PLN)
-28.12 Million
Avg. Volume
160.47 Thousand
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.62-32.9
- PE
- -
- EPS
- -
- Beta Value
- 0.711
- ISIN
- PLCLNPH00015
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Maciej Wieczorek Ph.D.
- Employee Count
- -
- Website
- https://www.celonpharma.com
- Ipo Date
- 2017-02-17
- Details
- Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
More Stocks
-
ENTRINTEnterprise International Limited
ENTRINT
-
JETAIRWAYSJet Airways (India) Limited
JETAIRWAYS
-
290650L&C Bio Co., Ltd
290650
-
OCAX
-
2388
-
DGE
-
GUERGuerrilla RF, Inc.
GUER
-
AGYTFAllergy Therapeutics plc
AGYTF